Stevens-Johnson Syndrome in Adult Patient Secondary to COVID-19 Infection: Case Report

Area of Science:

• Dermatology
• Virology
• Infectious Diseases

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents with diverse clinical symptoms.
• Cutaneous manifestations of COVID-19 are increasingly documented, ranging from rashes to vasculitis.
• Stevens-Johnson syndrome is a severe mucocutaneous reaction with various potential triggers.

Observation:

• A 45-year-old male presented with mucocutaneous symptoms consistent with Stevens-Johnson syndrome.
• The patient's presentation occurred in the context of the global COVID-19 pandemic.

Findings:

• This case highlights Stevens-Johnson syndrome as a potential, albeit rare, mucocutaneous manifestation of COVID-19.
• The study documents a specific instance linking SARS-CoV-2 infection to this severe dermatological reaction.

Implications:

• Recognizing Stevens-Johnson syndrome in COVID-19 patients is crucial for timely diagnosis and management.
• Further research is needed to understand the immunological mechanisms connecting SARS-CoV-2 and severe cutaneous adverse reactions.
• This case expands the spectrum of known COVID-19 dermatological presentations.